Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical differences between the newer antiarrhythmic agents.

A J Camm1

  • 1Department of Cardiology, St George's Hospital Medical School, London, UK.

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
|February 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atrial premature beats preceding episodes of paroxysmal atrial fibrillation: factorial analysis of a prediction system.

Pacing and clinical electrophysiology : PACE·1997
Same author

Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy.

Japanese circulation journal·1997
Same author

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

Circulation·1997
Same author

Chlamydia pneumoniae and coronary heart disease.

BMJ (Clinical research ed.)·1997
Same author

Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.

Lancet (London, England)·1997
Same author

Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation.

European heart journal·1997
Same journal

Incidence and Clinical Predictors of Cognitive Decline in Anticoagulated Patients with Atrial Fibrillation. The Strat-AF Study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same journal

Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation - insights from acute and chronic electroanatomic remapping in the randomized SINGLE-SHOT CHAMPION trial.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same journal

Pulmonary vein reconnection patterns after pentaspline pulsed field ablation for atrial fibrillation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same journal

Angioplasty for Pulmonary Vein Stenosis after Atrial Fibrillation Ablation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same journal

Compliance to direct oral anticoagulation therapy and clinical outcomes after catheter ablation for atrial fibrillation: a nationwide cohort study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same journal

Atrial cardiomyopathy as a multidomain disease: longitudinal evidence for autonomic remodelling.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
See all related articles

Newer class III antiarrhythmic drugs targeting potassium currents offer improved safety and efficacy. These agents provide more therapeutic options for managing cardiac arrhythmias, addressing limitations of older treatments.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Class I antiarrhythmic agents present significant safety concerns.
  • Research has shifted towards developing Class III antiarrhythmic drugs.

Purpose of the Study:

  • To review newer Class III antiarrhythmic agents.
  • To highlight their mechanisms of action and clinical efficacy.
  • To discuss their safety profile compared to existing therapies.

Main Methods:

  • Review of scientific literature on Class III antiarrhythmic drugs.
  • Analysis of mechanisms targeting potassium currents (I(Kr), I(Ks)) and sodium currents.
  • Evaluation of clinical trial data regarding efficacy and safety.

Main Results:

  • Dofetilide selectively blocks I(Kr).

Related Experiment Videos

  • Azimilide and ibutilide exhibit broader activity, blocking multiple ion channels.
  • Clinical investigations show these agents are effective and safer alternatives.

    • Conclusions:

    • Newer Class III antiarrhythmics offer enhanced safety and efficacy.
    • These drugs expand therapeutic choices for managing cardiac arrhythmias.
    • Advancements in Class III agents move closer to ideal arrhythmia management.